Neuland Laboratories
NEULANDLAB.NS
#5173
Rank
$0.97 B
Marketcap
$75.85
Share price
-0.59%
Change (1 day)
273.09%
Change (1 year)

P/E ratio for Neuland Laboratories (NEULANDLAB.NS)

P/E ratio as of March 2024 (TTM): 37.3

According to Neuland Laboratories's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 37.329. At the end of 2022 the company had a P/E ratio of 21.2.

P/E ratio history for Neuland Laboratories from 2019 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202221.2-36.45%
202133.428.47%
202026.056.09%
201916.7

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.